A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in ...
Dr. James McCaffrey of Microsoft Research says the technique is easy to tune, works well with small datasets and produces highly interpretable predictions, but there are also trade-off cons. The goal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback